These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 3108993)
1. [Experimental and preliminary observation on the ultimate influence of cyclosporin on chronic infection of mice by Trypanosoma cruzi]. Amato Neto V; Moreira AA; Campos R; Duarte MI; Pinto PL; de Sant'Ana EJ Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(5):219-21. PubMed ID: 3108993 [No Abstract] [Full Text] [Related]
2. Exacerbation of Trypanosoma cruzi infection in mice treated with the immunoregulatory agent cyclosporin A. Kierszenbaum F; Gottlieb CA; Budzko DB Tropenmed Parasitol; 1983 Mar; 34(1):4-6. PubMed ID: 6405514 [TBL] [Abstract][Full Text] [Related]
3. [Effect of cyclosporin and prednisone on the acute phase of experimental infection of mice by Trypanosoma cruzi]. Okumura M; Amato Neto V; Campos R; da Silva AF; Moreira AA; de Souza HB; Pinto PL; Matsubara L Rev Hosp Clin Fac Med Sao Paulo; 1990; 45(2):53-6. PubMed ID: 2135359 [TBL] [Abstract][Full Text] [Related]
4. Anti-Trypanosoma cruzi effects of cyclosporin A derivatives: possible role of a P-glycoprotein and parasite cyclophilins. Búa J; Fichera LE; Fuchs AG; Potenza M; Dubin M; Wenger RO; Moretti G; Scabone CM; Ruiz AM Parasitology; 2008 Feb; 135(2):217-28. PubMed ID: 17922928 [TBL] [Abstract][Full Text] [Related]
5. Animal experimental investigation into the activity of nifurtimox against Trypanosoma cruzi. Haberkorn A; Gönnert R Arzneimittelforschung; 1972 Sep; 22(9):1570-82. PubMed ID: 4630483 [No Abstract] [Full Text] [Related]
6. Thioridazine treatment modifies the evolution of Trypanosoma cruzi infection in mice. Rivarola HW; Fernández AR; Enders JE; Fretes R; Gea S; Suligoy M; Palma JA; Paglini-Oliva P Ann Trop Med Parasitol; 1999 Oct; 93(7):695-702. PubMed ID: 10715697 [TBL] [Abstract][Full Text] [Related]
7. [New process for screening of drugs in experimental infection with Trypanosoma cruzi]. Campos R; Amato Neto V; de Souza HB; Braz LM Rev Inst Med Trop Sao Paulo; 1991; 33(4):325-7. PubMed ID: 1844956 [TBL] [Abstract][Full Text] [Related]
8. Trypanosoma cruzi: dehydroepiandrosterone (DHEA) and immune response during the chronic phase of the experimental Chagas' disease. Caetano LC; Santello FH; Del Vecchio Filipin M; Brazão V; Caetano LN; Toldo MP; Caldeira JC; do Prado Júnior JC Vet Parasitol; 2009 Jul; 163(1-2):27-32. PubMed ID: 19446400 [TBL] [Abstract][Full Text] [Related]
9. [Reaction of the Trypanosoma cruzi strain to the experimental therapeutical response to Bay 2502 (results of long term treatment)]. Andrade SG; Figueira RM; Carvalho ML; Gorini DF Rev Inst Med Trop Sao Paulo; 1975; 17(6):380-9. PubMed ID: 815983 [No Abstract] [Full Text] [Related]
10. [Experimental study on the resistance of a strain of Trypanosoma cruzi to Bay 2502]. Andrade SG; Andrade ZA; Figueira RM Rev Inst Med Trop Sao Paulo; 1977; 19(2):124-9. PubMed ID: 408896 [No Abstract] [Full Text] [Related]
11. [Evaluation of the eventual activity of cyclosporin A in preventing the transmission, by blood transfusion, of Trypanosoma cruzi infection]. Amato Neto V; Pasternak J; de Souza ER; Costa AM; Matsubara L Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(4):195-6. PubMed ID: 9567370 [TBL] [Abstract][Full Text] [Related]
12. Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole. Caldas S; Santos FM; de Lana M; Diniz LF; Machado-Coelho GL; Veloso VM; Bahia MT Exp Parasitol; 2008 Mar; 118(3):315-23. PubMed ID: 17945216 [TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro effects of cyclosporin A on Trypanosoma cruzi. McCabe RE; Remington JS; Araujo FG Am J Trop Med Hyg; 1985 Sep; 34(5):861-5. PubMed ID: 3929634 [TBL] [Abstract][Full Text] [Related]
14. Interaction with host factors exacerbates Trypanosoma cruzi cell invasion capacity upon oral infection. Covarrubias C; Cortez M; Ferreira D; Yoshida N Int J Parasitol; 2007 Dec; 37(14):1609-16. PubMed ID: 17640647 [TBL] [Abstract][Full Text] [Related]
16. 5-Nitro-2-furyl derivative actives against Trypanosoma cruzi: preliminary in vivo studies. Cabrera E; Murguiondo MG; Arias MG; Arredondo C; Pintos C; Aguirre G; Fernández M; Basmadjián Y; Rosa R; Pacheco JP; Raymondo S; Di Maio R; González M; Cerecetto H Eur J Med Chem; 2009 Oct; 44(10):3909-14. PubMed ID: 19446929 [TBL] [Abstract][Full Text] [Related]
17. Trypanosoma cruzi: Genetic diversity influences the profile of immunoglobulins during experimental infection. dos Santos DM; Talvani A; Guedes PM; Machado-Coelho GL; de Lana M; Bahia MT Exp Parasitol; 2009 Jan; 121(1):8-14. PubMed ID: 18848935 [TBL] [Abstract][Full Text] [Related]
18. [In vivo and in vitro susceptibility of Trypanosoma cruzi to ketoconazole]. Rubiolo ER; Cano RC Rev Latinoam Microbiol; 1987; 29(4):395-401. PubMed ID: 3149794 [No Abstract] [Full Text] [Related]
19. Trypanosoma cruzi: the effects of zinc supplementation during experimental infection. Brazão V; Del Vecchio Filipin M; Caetano LC; Toldo MP; Caetano LN; do Prado JC Exp Parasitol; 2008 Apr; 118(4):549-54. PubMed ID: 18177642 [TBL] [Abstract][Full Text] [Related]
20. [Experimental infection of the monkey Cebus apella sp. by Trypanosoma cruzi. III. Value of xenodiagnosis and serodiagnosis in the chronic phase of the disease]. Granado N; Rassy MR; Nogaroto SL; Carvalhal S; de Almeida EA; Chaia G Rev Inst Med Trop Sao Paulo; 1983; 25(6):283-7. PubMed ID: 6424219 [No Abstract] [Full Text] [Related] [Next] [New Search]